Candida auris Screening in a Simple Setup: Introduction, When to Suspect it, Identification Methods,Confirmatory Identification, and Summary Table

Introduction of Candida auris Screening in a Simple Setup

Candida auris Screening in a Simple Setup is possible to presumptively identify Candida auris in a simple laboratory setup, though definitive identification typically requires advanced methods. In resource-limited or basic clinical microbiology labs, we can still suspect or screen for Candida auris using a combination of culture characteristics, resistance patterns, and simple tests.

Candida auris colony morphology
Fig. Candida auris colony morphology-Source: CDC

When to Suspect C. auris?

  • Rapid-growing yeast in high-risk patients (ICU, cancer).
  • Shows resistance to fluconazole.
  • Doesn’t form germ tubes.
  • Grows at 42°C and in 10% NaCl.
  • Misidentified by automated systems.

Identification Methods In a Simple Setup

1. Growth on Chromogenic Media (e.g., CHROMagar Candida)

  • Candida auris typically grows as pale pink to white colonies, but NOT green (like C. albicans), not metallic blue (like C. tropicalis).
  • However, C. auris may resemble C. glabrata or C. haemulonii on chromogenic media, so this is presumptive only.

2. Salt and Temperature Tolerance

  • C. auris can grow in:
    • 10% NaCl (Halotolerant)
    • 42°C incubation (Thermotolerant)
  • Set up Sabouraud dextrose agar (SDA with NaCl and incubate at 42°C for 48 hours.

3. Antifungal Resistance Profile

  • Test antifungal susceptibility using disc diffusion or MIC strips (if available).
  • C. auris typically shows:
    • Resistance to fluconazole (FLC)
    • Variable resistance to amphotericin B and echinocandins
  • If a Candida isolate shows multidrug resistance, suspect C. auris.

4. Colony Morphology on SDA

  • Smooth, shiny, white-to-cream-colored colonies.
  • Grows rapidly (24–48 hrs) at 37°C.

5. Gram Stain / Microscopy

  • Oval yeast cells; no pseudohyphae or germ tubes.
  • However, this is not sufficient alone for ID.

6. Sugar Assimilation (Optional)

  • You may perform basic sugar assimilation tests (e.g., dextrose, galactose, maltose, lactose).
  • C. auris is non-hemolytic, and its sugar assimilation profile differs from C. albicans.

What We CANNOT Do in Simple Labs:

  • MALDI-TOF MS
  • PCR or sequencing
  • VITEK-2 without an updated database may misidentify it as C. haemulonii or C. famata

Confirmatory Identification

The isolate is sent to the reference lab for:

  • MALDI-TOF MS (updated database)
  • PCR targeting the ITS/D1-D2 region
  • Whole-genome sequencing (if part of the outbreak)

Summary Table for Candida auris Screening

TestResult Suggestive of C. auris
ChromagarPale pink/white colonies
Germ tubeNegative
Growth at 42°CPositive
Growth in 10% NaClPositive
Fluconazole resistanceCommon
Germ tubeAbsent
MALDI-TOF (if available)Confirmatory

Keynotes

  • Emerging Multidrug-Resistant Yeast; Candida auris is a rapidly emerging fungal pathogen with resistance to multiple antifungals, including azoles, polyenes, and sometimes echinocandins.
  • Difficult to Identify in Routine Labs-It is often misidentified as C. haemulonii, C. famata, or C. lusitaniae by conventional systems (e.g., VITEK-2 without updated database).
  • Causes Invasive Infections: Common infections include candidemia, wound infections, and ventilator-associated pneumonia, especially in ICU and immunocompromised patients.
  • High Mortality Rates: Mortality from C. auris bloodstream infection ranges from 30% to 60%, particularly in critically ill or cancer patients.
  • Transmits Person-to-Person: Unlike other Candida species, C. auris spreads nosocomially (via healthcare contact, contaminated surfaces, or devices).
  • Grows at High Temperature and Salinity: It can grow at 42°C and in 10% NaCl, helping distinguish it from other Candida species.
  • No Germ Tube Formation: C. auris is germ tube negative and does not produce pseudohyphae, which helps rule out C. albicans.
  • Forms Biofilms on Medical Devices: Adheres to catheters, ventilators, and hospital surfaces, making eradication and infection control challenging.
  • Resistant to Fluconazole: >90% of isolates are resistant to fluconazole; some strains are pan-resistant to all major antifungal classes.
  • Requires Contact Precautions and Outbreak Control: Identification mandates notification, isolation, surface disinfection, and public health alert due to outbreak potential.

Further Readings

  1. https://www.cdc.gov/candida-auris/index.html
  2. https://my.clevelandclinic.org/health/diseases/25152-candida-auris
  3. https://www.chp.gov.hk/en/healthtopics/content/24/106835.html
  4. https://pmc.ncbi.nlm.nih.gov/articles/PMC8069182/
  5. https://www.betterhealth.vic.gov.au/health/conditionsandtreatments/Candida-auris
  6. https://doh.wa.gov/public-health-provider-resources/notifiable-conditions/candida-auris
  7. https://www.gov.uk/government/collections/candidozyma-auris
  8. https://www.publichealthontario.ca/en/Diseases-and-Conditions/Health-Care-Associated-Infections/Candida-auris
  9. https://pmc.ncbi.nlm.nih.gov/articles/PMC10495051/
  10. https://www.health.vic.gov.au/infectious-diseases/candida-auris-c-auris
  11. https://newsnetwork.mayoclinic.org/discussion/candida-auris-this-fungus-is-a-health-care-concern/
  12. https://www.nj.gov/health/cd/topics/cauris.shtml

Leave a Comment